Campbell & CO Investment Adviser LLC Makes New $601,000 Investment in QuidelOrtho Co. (NASDAQ:QDEL)

Campbell & CO Investment Adviser LLC purchased a new stake in shares of QuidelOrtho Co. (NASDAQ:QDELFree Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 8,154 shares of the company’s stock, valued at approximately $601,000.

Several other institutional investors and hedge funds have also recently modified their holdings of QDEL. Cetera Trust Company N.A purchased a new position in QuidelOrtho during the fourth quarter worth about $108,000. C M Bidwell & Associates Ltd. purchased a new stake in shares of QuidelOrtho during the 3rd quarter valued at approximately $123,000. Bfsg LLC acquired a new position in QuidelOrtho in the fourth quarter valued at approximately $146,000. William Blair Investment Management LLC purchased a new position in QuidelOrtho in the third quarter worth approximately $210,000. Finally, Wilbanks Smith & Thomas Asset Management LLC purchased a new position in QuidelOrtho in the fourth quarter worth approximately $227,000. Institutional investors and hedge funds own 99.00% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. UBS Group reaffirmed a “sell” rating and issued a $42.00 price target (down previously from $70.00) on shares of QuidelOrtho in a research note on Monday, March 4th. JPMorgan Chase & Co. lowered shares of QuidelOrtho from a “neutral” rating to an “underweight” rating and lowered their target price for the stock from $66.00 to $37.00 in a research note on Wednesday, February 14th. William Blair reissued a “market perform” rating on shares of QuidelOrtho in a research note on Wednesday, February 14th. Craig Hallum reaffirmed a “hold” rating on shares of QuidelOrtho in a research report on Wednesday, February 14th. Finally, Royal Bank of Canada cut their target price on QuidelOrtho from $81.00 to $68.00 and set an “outperform” rating on the stock in a research report on Thursday, May 9th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $59.00.

Get Our Latest Research Report on QDEL

QuidelOrtho Trading Down 2.1 %

NASDAQ QDEL opened at $41.67 on Friday. QuidelOrtho Co. has a one year low of $37.78 and a one year high of $89.11. The firm has a 50 day simple moving average of $42.31 and a 200-day simple moving average of $55.10. The firm has a market cap of $2.79 billion, a price-to-earnings ratio of -1.58 and a beta of 0.13. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.81 and a current ratio of 1.55.

QuidelOrtho (NASDAQ:QDELGet Free Report) last issued its quarterly earnings results on Wednesday, May 8th. The company reported $0.36 EPS for the quarter, missing the consensus estimate of $0.42 by ($0.06). QuidelOrtho had a negative net margin of 61.65% and a positive return on equity of 3.96%. The business had revenue of $711.00 million during the quarter, compared to analysts’ expectations of $697.33 million. Equities research analysts anticipate that QuidelOrtho Co. will post 2.09 EPS for the current fiscal year.

QuidelOrtho Profile

(Free Report)

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.

Featured Articles

Want to see what other hedge funds are holding QDEL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for QuidelOrtho Co. (NASDAQ:QDELFree Report).

Institutional Ownership by Quarter for QuidelOrtho (NASDAQ:QDEL)

Receive News & Ratings for QuidelOrtho Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QuidelOrtho and related companies with MarketBeat.com's FREE daily email newsletter.